Weisi Medical Surges with Two Consecutive 20% Gains: BCI New Products Still in Early Market Cultivation Phase

Source: Cailian Press

[20CM Two Consecutive Boards]VISHEE: New Products in the Brain-Computer Interface Field Still in Early Market Cultivation】According to the Sci-Tech Innovation Board Daily, VISHEE (688580.SH) issued an announcement on abnormal stock trading fluctuations. The company's main business focuses on the research, development, production, and sales of rehabilitation medical devices, with products widely used in psychiatric rehabilitation, pelvic and postpartum rehabilitation, and neurological rehabilitation. By the end of 2025, the company’s new products in the brain-computer interface field will still be in the early stage of market cultivation, primarily focusing on non-invasive technology routes. This represents a significant technical path difference from the current internationally leading invasive brain-computer interfaces. Related products have not yet achieved scaled sales, and their contribution to overall operating revenue remains relatively limited.